Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (136)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boyle, J. S.
Right arrow Articles by Lew, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyle, J. S.
Right arrow Articles by Lew, A. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 9, 1897-1906, Copyright © 1997 by Oxford University Press

ARTICLES

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

JS Boyle, C Koniaras and AM Lew
Burnet Clinical Research Unit, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

We examined the role of the cellular localization of antigen on the immune response after DNA immunization of mice with three forms of ovalbumin (OVA). DNA encoding OVA which was secreted (sOVA) generated 10- to 100-fold higher IgG responses with 50-and 100-fold higher levels of IgG1 than the cytoplasmic (cOVA) or membrane bound (mOVA) forms. An IgG2a predominance was seen only in cOVA and mOVA immunized mice. Although the antibody response was CD4+ T cell dependent, the differences in the antibody response could not be compensated for by provision of excess CD4+ T cell help in TCR transgenic mice. Together with our hapten-carrier studies, this would indicate that membrane or intracellular localization limits the availability of antigen for B cell priming which affects the magnitude and form of the antibody response. Surprisingly, stronger cytotoxic T lymphocyte (CTL) responses were generated for sOVA or mOVA than for cOVA via intramuscular (i.m.) injection. Since a cytoplasmic antigen should have best access to the canonical class I pathway for antigen presentation, our results indicate that priming of CTL responses after i.m. DNA immunization is probably by cross-presentation of antigen by non-transfected professional antigen-presenting cells. In contrast, intradermal immunization with cOVA produced optimal CTL responses but, as with mOVA, suboptimal antibody responses. This, together with our ex vivo RT- PCR analysis showing similar mRNA levels from all three constructs 7 days post-immunization, argues against the differential CTL response for i.m. injection to be due to dose.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
C. Trollet, Y. Pereira, A. Burgain, E. Litzler, M. Mezrahi, J. Seguin, M. Manich, M. R. Popoff, D. Scherman, and P. Bigey
Generation of High-Titer Neutralizing Antibodies against Botulinum Toxins A, B, and E by DNA Electrotransfer
Infect. Immun., May 1, 2009; 77(5): 2221 - 2229.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. Saxena, P. J. Coloe, and P. M. Smooker
Influence of Promoter, Gene Copy Number, and Preexisting Immunity on Humoral and Cellular Responses to a Vectored Antigen Delivered by a Salmonella enterica Vaccine
Clin. Vaccine Immunol., January 1, 2009; 16(1): 78 - 87.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
I. Caminschi, F. Ahmet, K. Heger, J. Brady, S. L. Nutt, D. Vremec, S. Pietersz, M. H. Lahoud, L. Schofield, D. S. Hansen, et al.
Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells
J. Exp. Med., October 29, 2007; 204(11): 2579 - 2590.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Orlandi, F. M. Venanzi, A. Concetti, H. Yamauchi, S. Tiwari, L. Norton, J. D. Wolchok, A. N. Houghton, and P. D. Gregor
Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine
Clin. Cancer Res., October 15, 2007; 13(20): 6195 - 6203.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
W. Mwangi, W. C. Brown, G. A. Splitter, C. J. Davies, C. J. Howard, J. C. Hope, Y. Aida, Y. Zhuang, B. J. Hunter, and G. H. Palmer
DNA Vaccine Construct Incorporating Intercellular Trafficking and Intracellular Targeting Motifs Effectively Primes and Induces Memory B- and T-Cell Responses in Outbred Animals
Clin. Vaccine Immunol., March 1, 2007; 14(3): 304 - 311.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. J. Steptoe, J. M. Ritchie, N. S. Wilson, J. A. Villadangos, A. M. Lew, and L. C. Harrison
Cognate CD4+ Help Elicited by Resting Dendritic Cells Does Not Impair the Induction of Peripheral Tolerance in CD8+ T Cells
J. Immunol., February 15, 2007; 178(4): 2094 - 2103.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. B. Arruda, D. Sim, P. R. Chikhlikar, M. Maciel Jr, K. Akasaki, J. T. August, and E. T. A. Marques
Dendritic Cell-Lysosomal-Associated Membrane Protein (LAMP) and LAMP-1-HIV-1 Gag Chimeras Have Distinct Cellular Trafficking Pathways and Prime T and B Cell Responses to a Diverse Repertoire of Epitopes
J. Immunol., August 15, 2006; 177(4): 2265 - 2275.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
A. Y. Chen, S. R. Fry, J. Forbes-Faulkner, G. Daggard, and T. K. S. Mukkur
Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice.
J. Med. Microbiol., July 1, 2006; 55(Pt 7): 923 - 929.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Lauterbach, A. Gruber, C. Ried, C. Cheminay, and T. Brocker
Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination.
J. Immunol., April 15, 2006; 176(8): 4600 - 4607.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Aoyama, K. Kamata, N. Yamanaka, Y. Takeuchi, M. Higashihara, and S. Kato
Characteristics of polyclonal anti-human nephrin antibodies induced by genetic immunization using nephrin cDNA
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1073 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. W. Stone, S. Barzee, V. Snarsky, K. Kee, C. A. Spina, X.-F. Yu, and R. S. Kornbluth
Multimeric Soluble CD40 Ligand and GITR Ligand as Adjuvants for Human Immunodeficiency Virus DNA Vaccines
J. Virol., February 15, 2006; 80(4): 1762 - 1772.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Beninati, A. Midiri, G. Mancuso, C. Biondo, M. Arigo, E. Gerace, S. Papasergi, M. Gambuzza, M. Boretti, W. Magliani, et al.
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci
J. Exp. Med., January 23, 2006; 203(1): 111 - 118.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
W. Mwangi, W. C. Brown, G. A. Splitter, Y. Zhuang, K. Kegerreis, and G. H. Palmer
Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection
J. Leukoc. Biol., August 1, 2005; 78(2): 401 - 411.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Chevalier, J. Lepault, B. Da Costa, and B. Delmas
The Last C-Terminal Residue of VP3, Glutamic Acid 257, Controls Capsid Assembly of Infectious Bursal Disease Virus
J. Virol., April 1, 2004; 78(7): 3296 - 3303.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J.-W. Youn, S.-H. Park, J. H. Cho, and Y. C. Sung
Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization
J. Virol., November 1, 2003; 77(21): 11596 - 11602.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Grosfeld, S. Cohen, T. Bino, Y. Flashner, R. Ber, E. Mamroud, C. Kronman, A. Shafferman, and B. Velan
Effective Protective Immunity to Yersinia pestis Infection Conferred by DNA Vaccine Coding for Derivatives of the F1 Capsular Antigen
Infect. Immun., January 1, 2003; 71(1): 374 - 383.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Rush, T. Mitchell, and P. Garside
Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways
J. Immunol., November 1, 2002; 169(9): 4951 - 4960.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Nelson, S. Mukherjee, C. Bundell, S. Fisher, D. van Hagen, and B. Robinson
Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective "Arming" of Tumor Antigen-Specific CTL
J. Immunol., May 1, 2001; 166(9): 5557 - 5566.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-F. Hung, K.-F. Hsu, W.-F. Cheng, C.-Y. Chai, L. He, M. Ling, and T-C. Wu
Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to a Gene Encoding the Extracellular Domain of Fms-like Tyrosine Kinase 3-Ligand
Cancer Res., February 1, 2001; 61(3): 1080 - 1088.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
J. M. Heile, Y.-L. Fong, D. Rosa, K. Berger, G. Saletti, S. Campagnoli, G. Bensi, S. Capo, S. Coates, K. Crawford, et al.
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
J. Virol., August 1, 2000; 74(15): 6885 - 6892.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J. H. Aberle, S. W. Aberle, S. L. Allison, K. Stiasny, M. Ecker, C. W. Mandl, R. Berger, and F. X. Heinz
A DNA Immunization Model Study with Constructs Expressing the Tick-Borne Encephalitis Virus Envelope Protein E in Different Physical Forms
J. Immunol., December 15, 1999; 163(12): 6756 - 6761.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H.-W. Chen, C.-H. Pan, M.-Y. Liau, R. Jou, C.-J. Tsai, H.-J. Wu, Y.-L. Lin, and M.-H. Tao
Screening of Protective Antigens of Japanese Encephalitis Virus by DNA Immunization: a Comparative Study with Conventional Viral Vaccines
J. Virol., December 1, 1999; 73(12): 10137 - 10145.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Suter, A. M. Lew, P. Grob, G. J. Adema, M. Ackermann, K. Shortman, and C. Fraefel
BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1
PNAS, October 26, 1999; 96(22): 12697 - 12702.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Fournillier, E. Depla, P. Karayiannis, O. Vidalin, G. Maertens, C. Trépo, and G. Inchauspé
Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization
J. Virol., September 1, 1999; 73(9): 7497 - 7504.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
P. Grob, V. E. C. J. Schijns, M. F. van den Broek, S. P. J. Cox, M. Ackermann, and M. Suter
Role of the Individual Interferon Systems and Specific Immunity in Mice in Controlling Systemic Dissemination of Attenuated Pseudorabies Virus Infection
J. Virol., June 1, 1999; 73(6): 4748 - 4754.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.